Recursion Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Recursion Pharmaceuticals's balance sheet done over the years? Its assets were worth $653,699,000 last year, which is less than in the previous period. 29% of Recursion Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $190,263,000, which means an decrease by -12% compared compared to last year.

Debt to Assets

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX): Debt to assets
2019 101431000 225.69M 222.51%
2020 298585000 504.87M 169.09%
2021 610345000 67.40M 11.04%
2022 701288000 215.48M 30.73%
2023 653699000 190.26M 29.11%

RXRX Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
391.56M549.91M285.11M262.12M69.88M
Short term investments
00231.44M00
Net receivables
3.09M2.75M9.09M156K151K
Inventory
01.28M1.55M5.04M5.28M
Other current assets
43.47M15.86M7.51M2.15M1.07M
Total current assets
438.13M569.81M534.71M269.47M76.39M
Non-current assets:
Property, Plant and Equipment
120.17M121.44M64.72M25.96M24.37M
Goodwill
52.05M801K801K801K0
Intangible assets
36.44M1.30M1.38M2.49M0
Long term investments
07.92M8.68M00
Other non-current assets
6.89M7.92M8.71M650K663K
Total non-current assets
215.56M131.47M75.62M29.10M25.03M
Total assets
653.69M701.28M610.34M298.58M101.43M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
36.42M56.72M10M10M0
Short term debt
12.27M6.04M1.50M1.54M544K
Total current liabilities
93.17M100.26M46.65M23.09M6.68M
Non-current liabilities:
Long term debt
44.51M44.95M9.97M14.12M15.62M
Deferred tax
00000
Other non-current liabilities
0-536K4.11M450.98M203.38M
Total non-current liabilities
97.09M115.21M20.74M481.77M219.01M
Total liabilities
190.26M215.48M67.40M504.87M225.69M
Data sourceData sourceData source